Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 54 Biliary Tract Neoplasms 23 Nasopharyngeal Carcinoma 22 Cholangiocarcinoma 22 Carcinoma, Non-Small-Cell Lung 22 Urinary Bladder Neoplasms 18 Breast Neoplasms 18 Neoplasm Metastasis 17 Lung Neoplasms 14 Lymphoma, Large B-Cell, Diffuse 13 Colorectal Neoplasms 12 Carcinoma, Transitional Cell 12 Non-Muscle Invasive Bladder Neoplasms 10 Recurrence 8 Ovarian Neoplasms 8 Triple Negative Breast Neoplasms 7 Sarcoma 7 Gallbladder Neoplasms 7 Neoplasms 6 Hodgkin Disease 6 Nasopharyngeal Neoplasms 5 Bile Duct Neoplasms 5 Adenocarcinoma 5 Uterine Cervical Neoplasms 4 Locally Advanced Pancreatic Cancer 4 Endometrial Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Pancreatic Adenocarcinoma 3 Osteosarcoma 3 Lymphoma 3

Interventions

Taxes 1 Specimen Handling 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Catheter Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pancreatic Cystic Neoplasm × Gemcitabine × Clear all

NCT07529483 2026-05-29

ERASE-Chemo

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting

Gastrointestinal

Pancreatic Cystic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡